• Isoproterenol Sulfate Dihydrate in SAN Assays

  2026-08-12

  Use Isoproterenol sulfate dihydrate to convert human SAN-plexus assembloids into a controllable model of beta-adrenergic stress. The workflow distinguishes acute GPCR-driven rate responses from slower innervation-associated maturation, helping researchers connect electrophysiology, cAMP/PKA signaling, and cardiac tissue organization.

• LTI6426 Enhances Panobinostat in Multiple Myeloma

  2026-08-12

  Robinson and colleagues report that the protein disulfide isomerase inhibitor LTI6426 markedly increases the antimyeloma activity of low-dose panobinostat in cell and mouse models, including a proteasome-inhibitor-resistant setting. The combination converges on endoplasmic-reticulum stress effectors, providing a mechanistic rationale for dose-sparing panobinostat regimens and nominating ATF3, DDIT3/CHOP, and DNAJB1 as candidate pharmacodynamic biomarkers.

• Human SAN-Plexus Assembloids Model Pacemaker Maturation

  2026-08-11

  This Cell Stem Cell study develops human pluripotent stem cell-derived assembloids that connect sinoatrial node, cardiac plexus, and atrial-like cardiac tissues to model innervation-associated pacemaker maturation. Functional analyses combined with human SAN spatial transcriptomics identify a CGPO-derived prosaposin–GPR37 signaling program that links neural input to pacemaker phenotype and conduction.

• Lysis Buffer for Reliable Mouse Genotyping

  2026-08-11

  This scenario-based guide explains how SKU H1002, Lysis buffer, components of the rapid genotyping kit for mouse tail, supports consistent genomic DNA release from mouse tail, toe, and ear tissue. It connects practical genotyping quality control with interpretation of downstream viability, proliferation, cytotoxicity, and translational studies while clearly separating product-supported evidence from local validation needs.

• Alosetron in 5-HT3 Gut Signaling Research

  2026-08-10

  Alosetron is a selective 5-HT3 receptor antagonist used as a research perturbation for serotonin receptor pharmacology, gastrointestinal motility modulation, and visceral pain signaling research. The compound provides a receptor-level tool for intestinal models, but current CDC42-YAP-EGF-mTOR evidence does not directly establish that Alosetron controls epithelial polarity or stem cell fate.

• Mubritinib–Albumin Recognition and Pharmacological Meaning

  2026-08-09

  The 2023 Molecular Pharmaceutics study used fluorescence, biochemical assays, and molecular docking to define how mubritinib binds human serum albumin (HSA). Its central contribution is linking moderate, site-I binding with measurable changes in albumin conformation and esterase-like function, providing a pharmacokinetic context for a mitochondrial electron transport chain inhibitor.

• L-Glutathione Reduced in GOT1 Assays

  2026-08-08

  L-Glutathione Reduced provides a controlled way to interrogate redox buffering alongside GOT1-driven metabolic changes. This article explains how to use reduced glutathione in cancer and GST assays without confusing a redox control with evidence of direct enzyme inhibition.

• 12-O-tetradecanoyl phorbol-13-acetate (TPA)

  2026-08-07

  12-O-tetradecanoyl phorbol-13-acetate (TPA) is a protein kinase C activator used to study ERK/MAPK pathway activation, tumor promotion, and signal transduction research. Its effects are model- and exposure-dependent, so solvent controls, pathway readouts, and time-matched controls are essential.

• Applied Approaches with S-Adenosylmethionine (SAM) in CNS Re

  2026-08-07

  S-Adenosylmethionine (SAM, ademetionine) is a gold-standard methyl donor for dissecting methylation reactions in proteins and DNA, with unique translational relevance for central nervous system and neuropsychiatric disease models. This article integrates bench-tested protocols, real-world troubleshooting, and insights from landmark CNS studies, enabling researchers to maximize data quality and reproducibility using APExBIO's high-purity SAM.

• Caffeine (1,3,7-trimethylpurine-2,6-dione): Bridging Cancer,

  2026-08-06

  Explore the multifaceted role of caffeine (1,3,7-trimethylpurine-2,6-dione) as a research tool in cancer inhibition, metabolic modulation, and its emerging relevance in cardiovascular disease models. This article delivers advanced mechanistic insight and practical guidance for translational lab applications.

• Caffeine as a Research Tool: Mechanistic Depth and Translati

  2026-08-06

  Explore how caffeine (1,3,7-trimethylpurine-2,6-dione) enables advanced mechanistic research, bridging cancer, metabolic, and neurobiological pathways. This article uniquely connects molecular action with practical assay strategies for scientists.

• AP-1 Inhibition Induces Ferroptosis in Multiple Myeloma via

  2026-08-05

  This study reveals that T-5224, a selective C-Fos/AP-1 inhibitor, triggers ferroptosis in multiple myeloma cells by suppressing the PI3K/AKT pathway. These findings uncover a new cell death mechanism for AP-1 inhibition in hematological malignancy and suggest expanded therapeutic potential for T-5224 beyond its established anti-inflammatory roles.

• Praeruptorin A Suppresses NF-κB and Inflammatory Genes in Ma

  2026-08-05

  This study demonstrates that Praeruptorin A (PA), a natural coumarin, inhibits NF-κB pathway activation and the expression of key inflammatory mediators in poly(I:C)-stimulated RAW264.7 macrophages. The findings highlight PA's potential as a molecular tool for dissecting viral inflammation pathways and identifying anti-inflammatory drug targets.

• CUDC-907: Technical Guidance for Dual PI3K and HDAC Inhibiti

  2026-08-04

  CUDC-907 enables controlled, simultaneous inhibition of PI3K and HDAC pathways in in vitro cancer research, supporting workflows targeting cell signaling, cell cycle arrest, and apoptosis. It is not suitable for diagnostic or therapeutic use and requires strict protocol adherence for reproducible data.

• Bradykinin (BA5201): Protocol Guidance for Vascular Research

  2026-08-04

  Bradykinin (BA5201) is a well-characterized endothelium-dependent vasodilator for use in vascular permeability modulation, smooth muscle contraction, and inflammation signaling pathway studies. This product is intended strictly for scientific research and should not be used in diagnostic or therapeutic workflows, or when long-term peptide solution stability is required.

15095 records 1/1007 page Next 12345 下5页 Last page